This bill prohibits the import of eight specific minerals (including copper, nickel, palladium, and platinum) from Russia or Russian entities starting 90 days after enactment. It directly affects U.S. importers and businesses relying on these Russian-sourced minerals. The ban ends one year after the President certifies Russia has ceased hostilities against Ukraine, but resumes immediately if Russia restarts military action, with no presidential waivers allowed. The law remains in effect until a new certification confirms Russia's cessation of hostilities.
This bill requires states to provide foster youth aged 14 and older with essential documents annually - such as credit reports, birth certificates, health records, and foster care verification - without cost, along with clear explanations of their rights and available services. It expands the Chafee Foster Care program to support youth transitioning from foster care through age 23, focusing on education, housing, health, job training, and life skills, while mandating that states consult directly with youth in planning these services. States must track participation and outcomes, including how many youth receive required documents and achieve key milestones like housing stability or educational goals. The bill directly affects foster youth and state child welfare agencies, aiming to improve their independence and well-being during critical transition years.
This bill establishes a 7-year demonstration program testing preferential treatment for U.S.-manufactured drugs in Medicare, Medicaid, and CHIP programs. It directs the Secretary to implement the program in at least 8 states, using tools like formulary preference or lower patient cost-sharing for drugs made by qualifying U.S. pharmaceutical companies. To qualify, drugs must be manufactured in the U.S. by companies meeting specific transparency, supply chain diversity, and inventory standards, including critical drugs identified in executive orders or deemed high-risk for shortages. The program aims to assess how U.S. manufacturing preferences affect drug access and costs within federal health programs. The Secretary must submit annual reports to Congress on program results and recommendations.
This bill creates a $10,000 annual tax credit for individuals who make non-directed living kidney donations (where donors don’t know the recipient’s identity) for five years (the donation year plus four subsequent years). It directly affects living kidney donors who qualify under these specific conditions, covering costs related to the donation process. The credit applies to kidneys removed after December 31, 2024, and expires December 31, 2034. The bill does not alter organ transplant recipient eligibility or medical procedures, focusing solely on financial incentives for donors.
HR 9125, the Patient Access to LTCH Care Act, adjusts Medicare payments for long-term care hospitals (LTCHs) treating patients with complex medical conditions. It increases payment rates by 5% or 10% for LTCHs based on the number of major complications or comorbidities a patient has, with specific thresholds tied to Medicare coding. The bill also sets annual caps on payment increases ($50,000 for 2025-2026, 110% of prior year for later years) and creates exceptions to ensure patients with severe wounds, specific diagnoses (like septicemia or pulmonary issues), or post-COVID care receive appropriate coverage. This directly affects LTCHs and Medicare beneficiaries with high-acuity conditions requiring specialized care.
The Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.
This bill amends the Social Security Act to include peer-to-peer mentoring services in key child welfare programs. It requires family preservation, support, reunification, and adoption services to incorporate mentoring by individuals with direct lived experience as caregivers, foster parents, or birth parents who navigated similar family crises. The policy change allows states to use existing federal funds for these peer mentoring services, which directly support caregivers at risk, foster parents, and birth parents working toward family reunification. The amendments apply to programs under Title IV of the Social Security Act, effective for fiscal years after enactment.
This bill creates a new Medicare payment model for emergency medical services (EMS) that allows coverage when ambulance providers deliver critical care on-site without transporting patients to a hospital. It directly affects Medicare beneficiaries receiving such on-site emergency care and ambulance providers who would previously not be reimbursed for non-transport services. The key provision requires Medicare to pay for these services at rates matching what would have been paid for transport, based on state protocols and emergency call responses, for a 5-year trial period. A report due 4 years after implementation will evaluate impacts on patient outcomes, system efficiency, and regional access.
The University Accountability Act imposes penalties on tax-exempt universities found in federal court to have violated Title VI of the Civil Rights Act of 1964, requiring them to pay $100,000 or 5% of their administrative compensation per violation. It mandates the IRS to review the tax-exempt status of institutions with more than two such violations and requires these institutions to report civil rights violations on their tax returns. If a violation determination is overturned, the penalty must be refunded. The bill applies to most public and private universities that are tax-exempt under federal law, directly affecting their financial obligations and reporting requirements.
HR 8815, the Youth and Family Engagement in Child Welfare Act, requires states to develop child welfare plans with direct input from youth and families who have experienced the system. Specifically, states must consult with children/youth in care, foster parents, adoptive parents, kinship caregivers, and community organizations during planning, and publicly post how they used youth feedback on state websites. The bill mandates these changes for all state child welfare programs, directly affecting how states design services for children in foster care, reunification, and adoption. It takes effect on October 1, 2026.
This bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.
The MEGOBARI Act directs the U.S. government to investigate and address democratic backsliding in Georgia. It requires reports within 90 days on Georgian corruption tied to Russian interests, sanctions evasion, and Russian intelligence assets, followed by potential sanctions against Georgian officials deemed responsible for undermining democracy or advancing Russian-style laws. The bill also establishes a U.S. democracy monitoring task force in Georgia and links additional U.S. aid - including trade negotiations, visa liberalization, economic packages, and defense support - to Georgia's progress toward fair elections and a free political environment. These provisions directly affect Georgia's government officials (who could face sanctions) and Georgia's eligibility for U.S. assistance. The bill does not impose new sanctions but mandates U.S. agencies to identify and sanction specific Georgian individuals under existing legal authorities.
